JW (Cayman) Therapeutics Co. Ltd. (HK:2126) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
JW (Cayman) Therapeutics Co. Ltd has announced the composition of its board of directors and the allocation of roles within four Board committees. The Board includes executive and non-executive members, with Dr. Yiping James Li serving as the Chairman. Key committee roles are held by members with specific oversight responsibilities, ensuring governance and strategic direction for the company.
For further insights into HK:2126 stock, check out TipRanks’ Stock Analysis page.